Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric Disorders

Complex Psychiatry · Published 2021-01-01 · DOI 10.1159/000515066

Authors being retrieved — see the publisher record. https://doi.org/10.1159/000515066

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2021

Related articles

• Inferring the Genetic Influences on Psychological Traits Using MRI Connectivity Predictive Models: Demonstration with Cognition · Complex Psychiatry · 2022 · Same journal
• History of Suicide Attempts and COVID-19 Infection in Veterans with Schizophrenia or Schizoaffective Disorder: Moderating Effects of Age and Body Mass Index · Complex Psychiatry · 2021 · Same journal
• Introducing Complex Psychiatry · Complex Psychiatry · 2020 · Same journal
• Psychobehavioural B-criteria of somatic symptom disorder are associated with somatic symptom reporting in a large sample of psychosomatic outpatients · Complex Psychiatry · 2024 · Same journal
• Addressing Emotional Dysregulation and Potential Pharmacogenetic Implication of 5-HTTLPR Genotype in Attention Deficit Hyperactivity Disorder · Complex Psychiatry · 2023 · Same journal
• The Validity of Brief Phenotyping in Population Biobanks for Psychiatric Genome-Wide Association Studies on the Biobank Scale · Complex Psychiatry · 2021 · Same journal
• Front & Back Matter · Complex Psychiatry · 2021 · Same journal
• Brain Lipids and Lipid Droplet Dysregulation in Alzheimer’s Disease and Neuropsychiatric Disorders · Complex Psychiatry · 2023 · Same journal
• Severe Anxiety, Stress, and Depression according to Life Satisfaction among Residents of Latin America · Complex Psychiatry · 2025 · Same journal
• Perspective on Beyond Statistical Significance: Finding Meaningful Effects · Complex Psychiatry · 2021 · Same journal